전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved188 programs
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Phase 1

iC9-CAR.B7-H3 T Cell Therapy (iC9-CAR.B7-H3 T Cell Therapy)

Breast Cancer; Relapse · B7-H3

#B7-H3#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
AntibodyLimited DatastalePeking Union Medical CollegePhase 2

iparomlimab + tuvonralimab (iparomlimab + tuvonralimab)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#Antibody#Phase2#monoclonal-antibody#PrecisionTherapy+1
Trials 1Status Recruiting
AntibodyLimited DatastalePeking Union Medical CollegePhase 2

ivonescimab + investigator-choice platinum doublet+ (ivonescimab + investigator-choice platinum doublet+)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#Antibody#Phase2#monoclonal-antibody#PrecisionTherapy+1
Trials 1Status Recruiting
CGTLimited DatastaleUniversity of PennsylvaniaPreclinical

lentiviral-based CART meso therapy (lentiviral-based CART meso therapy)

Subjects Who Have Received Lentiviral-based CART-meso Therapy · Multi-target

#Multi-target#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleEunice Kennedy Shriver National…Phase 2

lymphocyte gene therapy (lymphocyte gene therapy)

Mucopolysaccharidosis II · Mucopolysaccharidosis II

#MucopolysaccharidosisII#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleShenzhen SiBiono GeneTech Co.,L…Approved

p53 gene therapy (p53 gene therapy)

Advanced Malignant Thyroid Tumors · Advanced Malignant Thyroid Tumors

#AdvancedMalignantThyroidTumors#CGT#Approved#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleBeijing GoBroad HospitalPhase 1

prior-HSCT donor-derived FL-33 CAR T therapy (prior-HSCT donor-derived FL-33 CAR T therapy)

Refractory/Relapsed Acute Myeloid Leukaemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, pyrotinib and trastuzumab in combinition with neoadjuvant chemotherapy)

HER2-positive Breast Cancer; Neoadjuvant Therapy · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#HER2-positiveBreastCancer+2
Trials 1Status Recruiting

10 / 10 pages

← PreviousNext →